FALLON LYNNETTE C 4
4 · ClearPoint Neuro, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
ClearPoint Neuro (CLPT) Director Lynnette Fallon Sells Shares
What Happened
Lynnette Fallon, a director of ClearPoint Neuro (CLPT), had 12,417 restricted stock units (RSUs) settle into common shares on May 19, 2026. Following the vesting, 5,091 of those shares were sold on May 20, 2026 in an open-market transaction at a weighted average price of $11.14 per share, producing proceeds of $56,714. The RSU settlement is reported as an exercise/conversion-type event (conversion of the derivative right to shares).
Key Details
- Transaction dates: RSU settlement on 2026-05-19; open-market sale on 2026-05-20. Filing date: 2026-05-21 (timely).
- Sale price and proceeds: weighted average $11.14; range $11.04–$11.20; total proceeds $56,714.
- Shares involved: 12,417 RSUs vested into shares; 5,091 shares sold to the market.
- Purpose/footnotes: RSUs were granted May 22, 2025 and vested per schedule (F1). The sale was made under a Rule 10b5-1 trading plan to cover tax liability from the vesting (F2). F3 notes the price range and that the filer can provide per-price share counts on request.
- Shares owned after transaction: not specified in the provided filing.
Context
This was a scheduled RSU settlement with a partial, planned sale to cover taxes — a routine event for equity compensation and not necessarily a signal of personal views on the company. No outright purchases were reported. Purchases tend to be more informative about insider conviction; this filing documents a taxable-event-driven sale.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-05-19+12,417→ 53,318 total - Sale
Common Stock
[F2][F3]2026-05-20$11.14/sh−5,091$56,714→ 48,227 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-05-19−12,417→ 0 total→ Common Stock (12,417 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]This sale of shares was made pursuant to a Rule 10b5-1 trading plan to cover the tax liability incident to the vesting of 12,417 shares on May 19, 2026 under a restricted stock unit granted to the director on May 22, 2025.
- [F3]Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.04 to $11.20. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.